Alligator Bioscience appoints Gayle Mills as Chief Business Officer
Lund, Sweden, September 28, 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX) announced today the appointment of Gayle Mills as Chief Business Officer to lead the company´s Business Development activities. Ms. Mills will be a member of the executive management team at Alligator Bioscience. Gayle Mills is a renowned business development professional with an unmatched industry network and an extensive knowledge of the biotech and pharma landscape. She has a successful track record of executing large R&D collaborations and transactions and has held senior positions with Roche Bioscience,